A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
about
Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes.Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes.Human iPSC-Derived Cardiomyocytes for Investigation of Disease Mechanisms and Therapeutic Strategies in Inherited Arrhythmia Syndromes: Strengths and Limitations.Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies.An optogenetic arrhythmia model to study catecholaminergic polymorphic ventricular tachycardia mutations.Antiarrhythmic Effects of Carvedilol and Flecainide in Cardiomyocytes Derived from Catecholaminergic Polymorphic Ventricular Tachycardia Patients.
P2860
A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A human pluripotent stem cell ...... tient-specific drug responses.
@en
A human pluripotent stem cell ...... tient-specific drug responses.
@nl
type
label
A human pluripotent stem cell ...... tient-specific drug responses.
@en
A human pluripotent stem cell ...... tient-specific drug responses.
@nl
prefLabel
A human pluripotent stem cell ...... tient-specific drug responses.
@en
A human pluripotent stem cell ...... tient-specific drug responses.
@nl
P2093
P2860
P50
P356
P1476
A human pluripotent stem cell ...... atient-specific drug responses
@en
P2093
Aarti Dalal
Chadwick M Hales
Joshua T Maxwell
Mary B Wagner
Monalisa Singh
Peter S Fischbach
Qingling Wu
Rajneesh Jha
Zachary T Mceachin
P2860
P304
P356
10.1242/DMM.026823
P577
2016-08-04T00:00:00Z